Company research / ZIVO

Zivo Bioscience, Inc. (ZIVO)

CIK 0001101026 · OTC · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

For the year ended 2024-12-31, Zivo Bioscience, Inc. reported revenue of $157.2K. Revenue grew 468.6% from the prior annual period.

Key ratios (year ended 2024-12-31)

31.1%
Gross margin
-8498.9%
Operating margin
-8513.4%
Net margin
468.6%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-04-24

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.